Cargando…

Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients

Lewy bodies (LBs), which mainly consist of α-synuclein (α-syn), are neuropathological hallmarks of patients with Parkinson’s disease (PD). The fine structure of LBs is unknown, and LBs cannot be made artificially. Nevertheless, many studies have described fibrillisation using recombinant α-syn purif...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Katsuya, Yagi, Naoto, Ikemoto, Yuka, Yagi, Hisashi, Choong, Chi-Jing, Hayakawa, Hideki, Beck, Goichi, Sumi, Hisae, Fujimura, Harutoshi, Moriwaki, Taro, Nagai, Yoshitaka, Goto, Yuji, Mochizuki, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664933/
https://www.ncbi.nlm.nih.gov/pubmed/26621077
http://dx.doi.org/10.1038/srep17625
_version_ 1782403516317302784
author Araki, Katsuya
Yagi, Naoto
Ikemoto, Yuka
Yagi, Hisashi
Choong, Chi-Jing
Hayakawa, Hideki
Beck, Goichi
Sumi, Hisae
Fujimura, Harutoshi
Moriwaki, Taro
Nagai, Yoshitaka
Goto, Yuji
Mochizuki, Hideki
author_facet Araki, Katsuya
Yagi, Naoto
Ikemoto, Yuka
Yagi, Hisashi
Choong, Chi-Jing
Hayakawa, Hideki
Beck, Goichi
Sumi, Hisae
Fujimura, Harutoshi
Moriwaki, Taro
Nagai, Yoshitaka
Goto, Yuji
Mochizuki, Hideki
author_sort Araki, Katsuya
collection PubMed
description Lewy bodies (LBs), which mainly consist of α-synuclein (α-syn), are neuropathological hallmarks of patients with Parkinson’s disease (PD). The fine structure of LBs is unknown, and LBs cannot be made artificially. Nevertheless, many studies have described fibrillisation using recombinant α-syn purified from E. coli. An extremely fundamental problem is whether the structure of LBs is the same as that of recombinant amyloid fibrils. Thus, we used synchrotron Fourier transform infrared micro-spectroscopy (FTIRM) to analyse the fine structure of LBs in the brain of PD patients. Our results showed a shift in the infrared spectrum that indicates abundance of a β-sheet-rich structure in LBs. Also, 2D infrared mapping of LBs revealed that the content of the β-sheet structure is higher in the halo than in the core, and the core contains a large amount of proteins and lipids.
format Online
Article
Text
id pubmed-4664933
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46649332015-12-03 Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients Araki, Katsuya Yagi, Naoto Ikemoto, Yuka Yagi, Hisashi Choong, Chi-Jing Hayakawa, Hideki Beck, Goichi Sumi, Hisae Fujimura, Harutoshi Moriwaki, Taro Nagai, Yoshitaka Goto, Yuji Mochizuki, Hideki Sci Rep Article Lewy bodies (LBs), which mainly consist of α-synuclein (α-syn), are neuropathological hallmarks of patients with Parkinson’s disease (PD). The fine structure of LBs is unknown, and LBs cannot be made artificially. Nevertheless, many studies have described fibrillisation using recombinant α-syn purified from E. coli. An extremely fundamental problem is whether the structure of LBs is the same as that of recombinant amyloid fibrils. Thus, we used synchrotron Fourier transform infrared micro-spectroscopy (FTIRM) to analyse the fine structure of LBs in the brain of PD patients. Our results showed a shift in the infrared spectrum that indicates abundance of a β-sheet-rich structure in LBs. Also, 2D infrared mapping of LBs revealed that the content of the β-sheet structure is higher in the halo than in the core, and the core contains a large amount of proteins and lipids. Nature Publishing Group 2015-12-01 /pmc/articles/PMC4664933/ /pubmed/26621077 http://dx.doi.org/10.1038/srep17625 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Araki, Katsuya
Yagi, Naoto
Ikemoto, Yuka
Yagi, Hisashi
Choong, Chi-Jing
Hayakawa, Hideki
Beck, Goichi
Sumi, Hisae
Fujimura, Harutoshi
Moriwaki, Taro
Nagai, Yoshitaka
Goto, Yuji
Mochizuki, Hideki
Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients
title Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients
title_full Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients
title_fullStr Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients
title_full_unstemmed Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients
title_short Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients
title_sort synchrotron ftir micro-spectroscopy for structural analysis of lewy bodies in the brain of parkinson’s disease patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664933/
https://www.ncbi.nlm.nih.gov/pubmed/26621077
http://dx.doi.org/10.1038/srep17625
work_keys_str_mv AT arakikatsuya synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT yaginaoto synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT ikemotoyuka synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT yagihisashi synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT choongchijing synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT hayakawahideki synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT beckgoichi synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT sumihisae synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT fujimuraharutoshi synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT moriwakitaro synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT nagaiyoshitaka synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT gotoyuji synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients
AT mochizukihideki synchrotronftirmicrospectroscopyforstructuralanalysisoflewybodiesinthebrainofparkinsonsdiseasepatients